Susan Morse
These technologies introduce new considerations regarding safety and effectiveness across the total product life cycle.
HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.
The main reason for the increase is the expected end of the premium tax credits.
CMS is expected to release the MA and Part D star ratings next week, ahead of the Oct. 15 Medicare open enrollment.
The deal with Pfizer will reduce the price of the company’s prescription drugs for Medicaid to Most Favored Nation pricing.
Medicare and Medicaid reimbursement will continue, but Medicaid payments are dependent on federal appropriation.
Clinical research and trials will verify SpotitEarly’s early cancer detection, which uses trained canines and AI to identify odor signatures in breath samples.
The president says he will impose the tariffs on non-generic drugs unless manufacturers build plants in America.
“We're building a plane and flying it at the same time," said Christopher Kunney on what's happening with AI.
Five years after being acquired, rural hospitals were 30% less likely to offer obstetric services.